Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Lex Prospicit
Heriman, Amanda Regina Pallas
Unknown Affiliation
Law, Crime, Criminology & Criminal Justice

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Juridical Analysis of Doctors Engaging in Collusion with Pharmaceutical Companies in Prescription of Medications Heriman, Amanda Regina Pallas; Caroline; Hasian, Clarisa Permata; Tobing, Ega Yolanda Lumban; Alexander, Johan; Naibaho , Novia
Lex Prospicit Vol. 2 No. 2: July 2024
Publisher : Universitas Pelita Harapan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.19166/lp.v2i2.7359

Abstract

In Indonesia, the legal rules that regulate the prohibition of doctors receiving gifts from pharmaceutical companies have not had a significant impact because the existing regulations only exist in the realm of ethics and administration. As a result, the collaboration between doctors and pharmaceutical companies in prescribing drugs continues and has a negative impact on patients. This research analyses the actions of doctors and pharmaceutical companies colluding in prescribing drugs to patients. The purpose of this research is to understand the legal responsibility of doctors and pharmaceutical companies colluding in prescribing drugs to patients, and also to understand the comparison of prevention of collusion between doctors and pharmaceutical companies in drug marketing in Indonesia and the United States. This study uses normative legal research because this research is only intended for written regulations, so this research is closely related to literature because it requires secondary data. The findings of this study indicate that collusion between doctors and pharmaceutical companies, which involves unethical or illegal agreements, can result in civil legal liability. However, if we review the law in the United States, the United States has stronger regulations, better transparency, and stricter legal sanctions in preventing collusion between doctors and pharmaceutical companies in drug marketing compared to Indonesia.
Co-Authors Caroline Hasian, Clarisa Permata Johan alexander, Johan Naibaho , Novia Tobing, Ega Yolanda Lumban